[HTML][HTML] Therapeutic use and molecular aspects of ivabradine in cardiac remodeling: A review
Y Kamisah, HH Che Hassan - International Journal of Molecular Sciences, 2023 - mdpi.com
Cardiac remodeling can cause ventricular dysfunction and progress to heart failure, a
cardiovascular disease that claims many lives globally. Ivabradine, a funny channel (I f) …
cardiovascular disease that claims many lives globally. Ivabradine, a funny channel (I f) …
Hyperpolarization‐activated cyclic nucleotide‐gated channel inhibitor in myocardial infarction: Potential benefits beyond heart rate modulation
A Sripusanapan, P Yanpiset, S Sriwichaiin… - Acta …, 2024 - Wiley Online Library
Myocardial infarction (MI) and its associated complications including ventricular arrhythmias
and heart failure are responsible for a significant incidence of morbidity and mortality …
and heart failure are responsible for a significant incidence of morbidity and mortality …
[HTML][HTML] Ivabradine induces cardiac protection against myocardial infarction by preventing cyclophilin-A secretion in pigs under coronary ischemia/reperfusion
In response to cardiac ischemia/reperfusion, proteolysis mediated by extracellular matrix
metalloproteinase inducer (EMMPRIN) and its secreted ligand cyclophilin-A (CyPA) …
metalloproteinase inducer (EMMPRIN) and its secreted ligand cyclophilin-A (CyPA) …
[HTML][HTML] Pathophysiology and molecular mechanism of caveolin involved in myocardial protection strategies in ischemic conditioning
X Zhao, X Yang, Z An, L Liu, J Yong, H Xing… - Biomedicine & …, 2022 - Elsevier
Multiple pathophysiological pathways are activated during the process of myocardial injury.
Various cardioprotective strategies protect the myocardium from ischemia, infarction, and …
Various cardioprotective strategies protect the myocardium from ischemia, infarction, and …
Ivabradine in the management of COVID-19-related cardiovascular complications: a perspective
Besides acute respiratory distress syndrome, acute cardiac injury is a major complication in
severe coronavirus disease 2019 (COVID-19) and is associated with a poor clinical …
severe coronavirus disease 2019 (COVID-19) and is associated with a poor clinical …